Filing Details
- Accession Number:
- 0001082038-19-000004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-13 20:03:14
- Reporting Period:
- 2019-03-12
- Accepted Time:
- 2019-03-13 20:03:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082038 | Durect Corp | DRRX | Pharmaceutical Preparations (2834) | 943297098 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1755509 | Michael Arenberg | 10260 Bubb Road Cupertino CA 95014 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-03-12 | 10,000 | $0.80 | 24,426 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
